InsidersTradesSigma
Across 2 buy signals with a settled T+90 return. Return basis: close on the day after publication.
Explore the detailed record of transactions filed by Aubrey de Lavenu Harold Andre, Director. Director active across 1 company, notably CEN Biotech INC. In total, 2 disclosures have been recorded. History available since 2 April 2021. The latest transaction was filed on 2 April 2021 (Attribution). Regulator: SEC (Form 4). All data is openly available.
2 of 2 declarations
Harold Andre Aubrey de Lavenu is a Board Member at CEN Biotech Inc. He plays a key role in the company's governance, contributing to strategy and overseeing operations. His experience in the biotechnology sector is an asset for CEN Biotech.